Bft Financial Group »

Sensei Biotherapeutics shares owned by Bft Financial Group

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Bft Financial Group from 13F filings

Historical chart of Bft Financial Group investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Bft Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Bft Financial Group

Quarter filed Position value Share count Share price at filing
2023-06-30 $17k 15k 1.14
2023-03-31 $22k 15k 1.50
2022-06-30 $34k 15k 2.29
2022-03-31 $34k 15k 2.29
2021-09-30 $156k 15k 10.51

More positions owned by Bft Financial Group

Johnson & Johnson (JNJ)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard World Esg Us Stk Etf (ESGV)
Apple (AAPL)
Vanguard World Esg Intl Stk Etf (VSGX)
Amazon (AMZN)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Affirm Hldgs Com Cl A (AFRM)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares U S Etf Tr Int Rt Hdg C B (LQDH)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Sba Communications Corp Cl A (SBAC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)

View all positions for Bft Financial Group

Top funds holding Sensei Biotherapeutics

Newtyn Management
Vanguard Group
Geode Capital Management
Bridgeway Capital Management
Bank of America Corporation
BlackRock
Millennium Management
Northern Trust
Citadel Advisors
Two Sigma Advisers
Leo Wealth
Raymond James & Associates
Morgan Stanley
Deuterium Capital Management
Two Sigma Investments

View all funds holding Sensei Biotherapeutics